R03.0 Insurance Policy Changes

Q: What insurance policy changes affect code R03.0?

There are 6 tracked policy changes affecting code R03.0, including updates from Florida Blue, Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Q: Which payers have updated policy for code R03.0?

Payers that have issued tracked updates for code R03.0 include: Florida Blue, Aetna, Blue Cross & Blue Shield of Mississippi.

Q: How do I get notified when code R03.0 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code R03.0. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Q: Why do payers change policies for code R03.0?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

ICD-10 R03.0 is officially defined as "Elevated blood-pressure reading, without diagnosis of hypertension." code R03.0 is referenced in 6 tracked payer policy changes from Florida Blue, Aetna, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code R03.0 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Florida Blue · Effective Jul 1, 2026High impact
Every Reading Counts: Your Contribution to Better Blood Pressure Outcomes
Florida Blue has issued updated guidance on blood pressure management documentation and coding for HEDIS reporting. Providers must now document exact blood pressure readings (no rounding or ranges), utilize specific CPT II codes (3074F-3080F) based on systolic/diastolic thresholds, and assign appropriate ICD-10 codes for hypertensive conditions. This change emphasizes detailed documentation to support quality measure compliance and care management targeting.
Aetna · Identified Oct 2, 2026Medium impact
Cardiovascular Monitoring Equipment for Home Use: Pulse, Blood Pressure, Telemonitors, and Pacemaker Monitors (CPB 0548, reviewed 2026-08-21)
Aetna considers validated home blood pressure monitors medically necessary as an alternative to ambulatory blood pressure monitoring to confirm hypertension in members age 18 and older with office readings greater than 140 systolic or 90 diastolic. Validated blood pressure monitors are considered medically necessary for members receiving hemodialysis or peritoneal dialysis in the home, and validated blood pressure cuffs are considered medically necessary durable medical equipment for members with hypertension. Self-contained pacemaker monitors, including audible and visible signal monitors, digital electronic monitors, and a specialized telephone attachment for trans-telephonic transmission of results, are considered medically necessary for members with cardiac pacemakers. Automated oscillometer serial blood pressure monitors for home use, AngelMed Guardian, CardioMEMS pillow and components, home and implantable congestive heart failure monitors, implantable inferior vena cava sensors, implantable wireless pulmonary artery pressure monitors for heart failure, Zoll Heart Failure and Arrhythmia Management System, bioelectrical impedance analysis, and non-invasive central blood pressure assessment with SphygmoCor are considered experimental, investigational, or unproven. Pulse tachometers do not meet Aetna's definition of covered durable medical equipment.
Aetna · Identified Aug 15, 2026Medium impact
Chronic Pain Rehabilitation Programs (CPB 0237, reviewed 2026-04-23)
Aetna's Clinical Policy Bulletin 0237 sets medical necessity criteria for chronic pain rehabilitation programs. Outpatient programs are medically necessary when the member has had chronic pain for more than 3 months, has documented failure or inadequate response to standard single-modality treatment, has persistent limitations in daily or social or vocational functioning, and has a physician referral and a pre-program psychological and behavioral health evaluation. Inpatient programs for up to 21 days require refractory pain plus two or more listed intractable pain criteria, and several conditions, including prior failure of an adequate multidisciplinary program, aggressive or violent behavior, and imminent suicidal tendencies, are considered not medically necessary.
Aetna · Identified Aug 15, 2026Medium impact
Cardiovascular Monitoring Equipment for Home Use: Pulse, Blood Pressure, Telemonitors, and Pacemaker Monitors (CPB 0548, reviewed 2025-08-22)
Aetna considers validated home blood pressure monitors medically necessary as an alternative to ambulatory blood pressure monitoring to confirm hypertension in members age 18 and older with office readings greater than 140 systolic or 90 diastolic, when the cuff is prescribed by a physician, is an arm device, has the correct cuff size assessed and provided by the vendor, and only one cuff per 5 years is considered medically necessary. Validated blood pressure monitors are also considered medically necessary for members receiving hemodialysis or peritoneal dialysis in the home, and self-contained pacemaker monitors are considered medically necessary for members with cardiac pacemakers. Pulse tachometers do not meet Aetna's definition of covered DME, and the following are considered experimental, investigational, or unproven: AngelMed Guardian, automated oscillometer serial blood pressure monitors for home use, bioelectrical impedance analysis, CardioMEMS, home congestive heart failure telemonitoring devices, implantable congestive heart failure monitors, the implantable inferior vena cava sensor, non-invasive central blood pressure assessment with the SphygmoCor System, and the Zoll Heart Failure and Arrhythmia Management System for monitoring pulmonary fluid levels. The bulletin is titled CPB 0548, reviewed 2025-08-22, with a last review of 08/21/2026.
Aetna · Identified Aug 12, 2026Medium impact
Automated Ambulatory Blood Pressure Monitoring (CPB 0025, reviewed 2026-03-12)
Aetna considers automated ambulatory blood pressure monitoring medically necessary when a member meets one of the listed criteria: at least two elevated office readings taken on separate days to identify 'white coat' hypertension; episodic hypertension with symptoms suggesting an adrenal tumor and repeatedly normal office readings; hypotensive symptoms or syncope thought related to antihypertensive medications; syncope evaluated with a 24-hour Holter monitor; nocturnal angina; resistant hypertension before an invasive investigation for secondary causes; or autosomal dominant polycystic kidney disease in children and young adults 30 years of age or younger. Monitoring for less than 24 hours or more than 3 days is not considered medically necessary, and repeat testing is not generally necessary more often than every 6 months. Aetna considers the use experimental, investigational, or unproven for heart failure, for pregnant women who do not meet the criteria, for diagnosing malignant hypertension, for members with an irregular cardiac rhythm such as atrial fibrillation, for routine monitoring to establish a hypertension diagnosis or evaluate treatment response, and for routine use before continuous positive airway pressure (CPAP) therapy.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure
Automated 24-hour ambulatory blood pressure monitoring may be considered medically necessary for individuals with elevated office blood pressure when it is performed one time to differentiate between white coat hypertension and true hypertension, the office blood pressure elevation is in the mild-to-moderate range (<180/110 mm Hg) and does not require immediate treatment with medications, and there is an absence of hypertensive end-organ damage on physical examination and laboratory testing. All other uses are considered investigational, including repeated testing in individuals with persistently elevated office blood pressure and monitoring of treatment effectiveness. For pediatric individuals, the policy follows the 2022 American Heart Association guidelines on ambulatory blood pressure monitoring in children and adolescents, including selecting a device with a cuff size appropriate to the child and using pediatric normative data for thresholds.

Watch R03.0

Get one email when a payer policy names R03.0, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code R03.0?

There are 6 tracked policy changes affecting code R03.0, including updates from Florida Blue, Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code R03.0?

Payers that have issued tracked updates for code R03.0 include: Florida Blue, Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code R03.0 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code R03.0. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code R03.0?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Every Reading Counts: Your Contribution to Better Blood Pressure Outcomes

Cardiovascular Monitoring Equipment for Home Use: Pulse, Blood Pressure, Telemonitors, and Pacemaker Monitors (CPB 0548, reviewed 2026-08-21)

Chronic Pain Rehabilitation Programs (CPB 0237, reviewed 2026-04-23)

Cardiovascular Monitoring Equipment for Home Use: Pulse, Blood Pressure, Telemonitors, and Pacemaker Monitors (CPB 0548, reviewed 2025-08-22)

Automated Ambulatory Blood Pressure Monitoring (CPB 0025, reviewed 2026-03-12)

Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure

What insurance policy changes affect code R03.0?

Which payers have updated policy for code R03.0?

How do I get notified when code R03.0 policy changes?

Why do payers change policies for code R03.0?